Method and basis set investigation for trans-platinum(II) oxime complex

Year 2015, Volume: 36 Issue: 2, 1 - 10, 21.03.2015

Koray Sayın Duran Karakaş

Abstract

The optimized molecular structure and stretching frequencies of platinum(II) oxime complex were investigated with HF, MP2, pure and hybrid DFT methods. CEP-4G, CEP-31G, CEP-121G, LANL2DZ, LANL2MB and SDD basis sets were used in calculations. Correlation coefficients of bond lengths and angles, computational job cpu time and stretching frequencies were used to determine the best method and basis set. The results show that HF/CEP-31G is the best level for bond lengths, angles and computational job cpu time.  BPW91/CEP-31G is the best levels for stretching frequencies of oximato-bridged Pt(II) complex.

Keywords

Pt(II) oxime complex, Theoretical Study, Ab Initio and DFT methods, Basis Sets

References

• Raymond, E., Faivre, S., Chaney, S., Woynarowski, J., Cvitkovic, E., 2002. Cellular and Molecular Pharmacology of Oxaliplatin. Mol Cancer Ther. 1, 227-238.
• Raymond, E., Chaney, S. G., Taamma, A., Cvitkovic, E., 1998. Oxaliplatin: A review of preclinical and clinical studies. Ann. Oncol. 9, 1053-1071.
• Fuertes, M. A., Castilla, J., Alonso, C., Perez, J. M., 2003. Cisplatin Biochemical Mechanism of Action: From Cytotoxicity to Induction of Cell Death Through Interconnections Between Apoptotic and Necrotic Pathways. Curr. Med. Chem. 10, 257-266.
• Ong, S. T., Vogelzang, N. J., 1996. Chemotherapy in malignant pleural mesothelioma. A review. J. Clin. Oncol. 14, 1007-1017.
• Weiss, R. B., Christian, M. C., 1993. New Cisplatin Analogues in Development. Drugs. 46, 360- 377.
• Cleare, M. J., Hoeschele, J. D., 1973. Antilt umour Platinum Compounds. Platinum Met Rev. 17, 2-13.
• Cleare, M. J., Hoeschele, J. D., 1973. Studies on the antitumor activity of group VIII transition metal complexes. Part I. Platinum (II) complexes. Bioinorg Chem. 2, 187-210.
• Endresi, H., 1985. A hydrogen-bridged dimeric stacked structure in a dioximato complex: (oxamide [Pt(C2H5N4O2)(C2H5N4O2)]I.2H2O. Acta Cryst. C41, 1047-1049. oxime) platinum (II) iodide dihydrate,
• Guedes da Silva, M. F. C., Izotova, Y. A., Pombeiro, A. J. L., Kukushkin, V. Y., 1998. Manifestation of redox duality of 2-propanone oxime: Pt(II)-assisted reduction versus Pt (IV) - mediated oxidation of Me2O= NOH species. Inorg. Chim. Acta. 277, 83-88.
• Makarycheva-Mikhailova, A. V., Haukka, M., Bokach, N. A., Garnovskii, D. A., Galanski, M., Keppler, B. K., Pomberio, A. J. L., Kukushkin, V. Y., 2002. Platinum(IV)-mediated coupling of dione monoximes and nitriles: a novel reactivity pattern of the classic oxime-based chelating ligands. New J. Chem. 26, 1085-1091.
• Köcher, S., Lutz, M., Spek, A. L., Walfort, B., Rüffer, T., van Klink, G. P. M., van Koten, G., Lang, H., 2008. Oxime-substituted NCN-pincer palladium and platinum halide polymers through non-covalent hydrogen bonding (NCN = [C6H2(CH2NMe2)2-2,6]−). Journal of Organometallic Chemistry. 693, 2244-2250.
• Quiroga, A. G., Cubo, L., de Blas, E., Aller, P., Navarro-Ranninger, C., 2007. Trans platinum complexes design: One novel water soluble oxime derivative that contains aliphatic amines in transconfiguration. J. Inorg. Biochem. 101, 104-110.
• Zorbas-Seifried, S., Jakupec, M. A., Kukushkin, N. V., Groessl, M., Hartinger, C. G., Semenova, O., Zorbas, H., Kukushkin, V. Y., Keppler, B. K., 2007. Reversion of Structure-Activity Relationships of Antitumor Platinum Complexes by Acetoxime but Not Hydroxylamine Ligands. Mol. Pharmacol. 71, 357-365.
• Scaffidi-Domianello, Y. Y., Meelich, K., Jakupec, M. A., Arion, V. B., Kukushkin, V. Y., Galanski, M., Keppler, B. K., 2010. Novel Cis- and Trans-Configured Bis(oxime)platinum(II) Complexes: Synthesis, Characterization, and Cytotoxic Activity. Inorg. Chem. 49, 5669-5678.
• Bartel, C., Bytzek, A. K., Scaffidi-Domianello, Y. Y., Grabmann, G., Jakupec, M. A., Hartinger, C. G., Galanski, M., Keppler, B. K., 2012. Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds. Biol. Inorg. Chem. 17, 465-474.
• Karaker, A. J., Hoeschele, J. D., Elliott, W. L., Showalter, H. D., Hollis, L. S., Sercel, A. D., Farrell, N. P., 1992. Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups. J. Med. Chem. 35, 4526- 4532.
• Wu, P. K., Qu, Y., Van Houten, B., Farrell, N., 1994. Chemical reactivity and DNA sequence specificity of formally monofunctional and bifunctional bis(platinum) complexes. J. Inorg. Biochem. 54, 207-220.
• Farrell, N., Appleton, T. G., Qu, Y., Roberts, J. D., Fontes, A. P. S., Skov, K. A., Wu, P., Zou, Y., 1995. Effects of Geometric Isomerism and Ligand Substitution in Bifunctional Dinuclear Platinum Complexes on Binding Properties and Conformational Changes in DNA. Biochemistry. 34, 15480-15486.
• Qu, Y., Bloemink, M. J., Reedijk, J., Hambley, T. W., Farrell, N., 1996. Dinuclear Platinum Complexes Form a Novel Intrastrand Adduct with d(GpG), an anti−syn Conformation of the Macrochelate As Observed by NMR and Molecular Modeling. J. Am. Chem. Soc. 118, 9307- 9313.
• Farrell, N., Valsecchi, E. M. M., Di Domenico, R., Da Re, G., Manzotti, C., Pezzoni, G., Giuliani, F. C., Spinelli, S., 1997. Chemical and biological properties of a novel bifunctional triplatinum phase I clinical agent. J. Inorg. Biochem. 67, 173.
• Qu, Y., Farrell, N., Kasparkova, J., Brabec, V., 1997. DNA binding of properties of trinuclear platinum complex. J. Inorg. Biochem. 67, 174.
• Perego, P., Caserini, C., Gatti, L., Carenini, N., Romanelli, S., Supino, R., Colangelo, D., Viano, I., Leone, R., Spinelli, S., Pezzoni, G., Manzotti, C., Farrell, N., Zunino, F., 1999. A Novel Trinuclear Platinum Complex Overcomes Cisplatin Resistance in an Osteosarcoma Cell System. Mol. Pharmacol. 55, 528-534.
• Kloster, M. B. G., Hannis, J. C., Muddiman, D. C., Farrell, N., 1999. Consequences of Nucleic Acid Conformation on the Binding of a Trinuclear Platinum Drug. Biochemistry. 38, 14731- 14737.
• Qu, Y., Rauter, H., Fontes, A. P. S., Bandarage, R., Kelland, L. R., Farrell, N., 2000. Synthesis, Characterization, and Cytotoxicity of Trifunctional Dinuclear Platinum Complexes:  Comparison of Effects of Geometry and Polyfunctionality on Biological Activity. J. Med. Chem. 43, 3189- 3192.
• Cox, J. W., Berners-Price, S. J., Davies, M. S., Qu, Y. Farrell, N., 2001. Kinetic Analysis of the Stepwise Formation of a Long-Range DNA Interstrand Cross-link by a Dinuclear Platinum Antitumor Complex:  Evidence for Aquated Intermediates and Formation of Both Kinetically and Thermodynamically Controlled Conformers. J. Am. Chem. Soc. 123, 1316-1326.
• Fan, D., Yang, X., Wang, X., Zhang, S., Mao, J., Ding, J., Lin, L., Guo, Z., 2007. A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity. J. Biol. Inorg. Chem. 12, 655- 665.
• Scaffidi-Domianello, Y. Y., Legin, A. A., Jakupec, M. A., Roller, A., Kukushkin, V. Y., Galanski, M., Keppler, B. K., 2012. Novel Oximato-Bridged Platinum(II) Di- and Trimer(s): Synthetic, Structural, and in Vitro Anticancer Activity Studies. Inorg. Chem. 51, 7153-7163.
• Giese, B., Deacon, G. B., Kuduk-Jaworska, J., McNaughton, D., 2002. Density functional theory and surface enhanced Raman spectroscopy characterization of novel platinum drugs. Biopolymers. 67, 294-297.
• Delp, S. A., Munro-Leighton, C., Khosla, C., Templeton J. L., Alsop N. M., Gunnoe T. B., Cundari T. R., 2009. Combined experimental and computational study of W(II), Ru(II), Pt(IV) and Cu(I) amine and amido complexes using 15N NMR spectroscopy. Journal of Organometallic Chemistry. 694, 1549-1556.
• Wysokinski, R., Kuduk-Jaworska, J., Michalska, D., 2006. Electronic structure, Raman and infrared spectra, and vibrational assignment of carboplatin. Density functional theory studies. J Mol Struct.: THEOCHEM. 758, 169-179.
• Tornaghi, E., Andreeoni, W., Carloni, P., Hutter, J., Parinello, M., 1995. Carboplatin versus cisplatin: density functional approach to their molecular properties. Chem. Phys. Lett. 246, 469- 474.
• Adamo, C., Barone, V., 1998. Exchange functionals with improved long-range behavior and adiabatic connection methods without adjustable parameters: The mPW and mPW1PW models. J. Chem. Phys. 108, 664-675.
• Gao, H., 2011. Theoretical studies of molecular structures and properties of platinum (II) antitumor drugs. Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy. 79, 687-693.
• Dennington II R. D.; Keith T.A.; Millam J.M. GaussView 5.0, Wallingford, CT, 2009.
• Frisch M J, Trucks G W, Schlegel H B, Scuseria G E, Robb M A, Cheeseman J R, Scalmani G, Barone V, Mennucci B & Petersson G A, et al. Gaussian, Inc., Wallingford CT, 2010.
• Stephens, P. J., Devlin, F. J., Chabalowski, C. F., Frisch, M. J., 1994. Ab Initio Calculation of Vibrational Absorption and Circular Dichroism Spectra Using Density Functional Force Fields. J. Phys. Chem. 98, 11623-11627.
• Becke, A. D., 1993. Density functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 98, 5648-5652.
• Moores, A., Mezailles, N., Ricard, L., Jean, Y., le Floch, P., 2004. η2-Palladium and Platinum(II) Complexes of a λ4-Phosphinine Anion:  Syntheses, X-ray Crystal Structures, and DFT Calculations. Organometallics. 23, 2870-2875.
• Lee, C., Yang, W., Parr, R. G., 1998. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B. 37, 785-789. 10